Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Disposable Colonoscope Assists Colorectal Cancer Screening

By HospiMedica International staff writers
Posted on 14 Dec 2014
An advanced, single use, self-propelled colonoscope offers omnidirectional colorectal cancer (CC) screening.

The Aer-O-Scope System consists of two primary components. The first is the scanning colonoscope component, with a novel optical system that maximizes visualization of the entire colonic mucosa, including behind haustral folds, thanks to advanced optics that enable 360° panoramic visualization, as well as a front view similar to that of conventional colonoscopy. A soft multilumen tube and pneumatic mechanism, directed by pressure measurement control software, makes use of balloons and low pressure CO2 to provide self-propelled intubation and advancement within the colon.

The second component is the Aer-O-Scope work station, which provides the elements to operate the disposable scanner. These include CO2, water, suction and air pressure, and the power supply for the camera and illumination. The work station also receives and processes transmitted data from the camera and scanner. The work station physician interface is equipped with an ergonomic joystick for intuitive control of navigation, insufflation, irrigation, and suction. The Aer-O-Scope Colonoscope System is a product of GI View (Ramat Gan, Israel), and has been approved by the US Food and Drug Administration (FDA).

“Aer-O-Scope is the only colorectal screening product that is single use, self-propelled and has 360° omnidirectional visualization,” said Tal Simchony, MD, CEO of GI-View. “This enables the physician to observe all the mucosa of the colon, including behind folds, which is critical for a complete colonic assessment. If a polyp is there, Aer-O-Scope will allow the physician the best possible chance of finding it.”

Colonoscopy involves the endoscopic examination of the entire large bowel and the distal part of the small bowel via the anus, and has become a primary routine screening test for CC in people who are over 50 years of age. Among people who have had an initial colonoscopy that found no polyps, the risk of developing CC within five years is extremely low, and there is therefore no need for those people to have another colonoscopy sooner than five years after the first screening.

Related Links:

GI View



Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Baby Warmer
THERMOCARE Convenience
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get complete access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new risk assessment tool determines patient-specific risks of developing unfavorable outcomes with heart failure (Photo courtesy of 123RF)

Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients

Heart failure is a serious condition where the heart cannot pump sufficient blood to meet the body's needs, leading to symptoms like fatigue, weakness, and swelling in the legs and feet, and it can ultimately... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.